[Drug-eluting stents: indications, limits and future development].
Chevalier
B
B
Service de cardiologie, hôpital Charles Nicolle, Rouen.
Blanchard
D
D
Berland
J
J
Carrié
D
D
Gilard
M
M
Hanssen
M
M
Louvard
Y
Y
Eltchaninoff
H
H
D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use; D020099:Coated Materials, Biocompatible; D003324:Coronary Artery Disease / Q000601:surgery*; D004867:Equipment Design; D006801:Humans; D017239:Paclitaxel / Q000008:administration & dosage / Q000627:therapeutic use; D020123:Sirolimus / Q000008:administration & dosage / Q000627:therapeutic use; D015607:Stents / Q000009:adverse effects
D000900:Anti-Bacterial Agents; D020099:Coated Materials, Biocompatible; D017239:Paclitaxel; D020123:Sirolimus